Legal & General Group’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-151
Closed -$17K 3589
2022
Q1
$17K Hold
151
﹤0.01% 3277
2021
Q4
$14K Hold
151
﹤0.01% 3383
2021
Q3
$13K Buy
151
+27
+22% +$2.66K ﹤0.01% 3401
2021
Q2
$15K Buy
124
+68
+121% +$9.41K ﹤0.01% 3375
2021
Q1
$9K Sell
56
-5
-8% -$848 ﹤0.01% 3403
2020
Q4
$9K Hold
61
﹤0.01% 3366
2020
Q3
$11K Buy
61
+10
+20% +$1.64K ﹤0.01% 3195
2020
Q2
$6K Buy
+51
New +$5.19K ﹤0.01% 3368
2019
Q3
Sell
-11
Closed -$1K 3386
2019
Q2
$1K Hold
11
﹤0.01% 3488
2019
Q1
$1K Hold
11
﹤0.01% 3343
2018
Q4
$1K Hold
11
﹤0.01% 3377
2018
Q3
$1K Hold
11
﹤0.01% 3384
2018
Q2
$31K Buy
+11
New +$25.4K ﹤0.01% 3000
2018
Q1
Sell
-5
Closed -$11K 3288
2017
Q4
$11K Hold
5
﹤0.01% 3226
2017
Q3
$9K Hold
5
﹤0.01% 3281
2017
Q2
$6K Sell
5
-16
-76% -$21.4K ﹤0.01% 3340
2017
Q1
$34K Buy
21
+5
+31% +$9.15K ﹤0.01% 2948
2016
Q4
$29K Buy
16
+7
+78% +$15.3K ﹤0.01% 3040
2016
Q3
$23K Hold
9
﹤0.01% 2791
2016
Q2
$23K Hold
9
﹤0.01% 2815
2016
Q1
$36K Hold
9
﹤0.01% 2543
2015
Q4
$43K Hold
9
﹤0.01% 2527
2015
Q3
$16K Hold
9
﹤0.01% 2744
2015
Q2
$81K Buy
+9
New +$85.9K ﹤0.01% 2269

Other funds holding IMUX

Legal & General Group's IMUX Position: Q2 2022 in Review

Legal & General Group sold out of Immunic (IMUX) in Q2 2022, closing a stake of 151 shares — an estimated $17K sold.

Legal & General Group first reported a position in IMUX in Q2 2015 and held it in 24 quarters. The position peaked at $81K in Q2 2015. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Legal & General Group reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 151 Immunic shares in Q2 2022, an estimated $17K.
  • Legal & General Group first reported a position in Immunic in Q2 2015 and held it in 24 quarters.
  • Legal & General Group's Immunic position peaked at $81K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.